Business Description
Poniard Pharmaceuticals Inc
NAICS : 325412
SIC : 2835
ISIN : US7324494001
Description
Poniard Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of cancer therapeutics. Its product candidate is picoplatin, a new generation platinum-based cancer therapy.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 99.96 | |||||
9-Day RSI | 98.41 | |||||
14-Day RSI | 93.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PARD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Poniard Pharmaceuticals Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -12 | ||
| Beta | 104.4581 | ||
| 3-Year Sharpe Ratio | 0.44 | ||
| 3-Year Sortino Ratio | 3 | ||
| Volatility % | 912.59 | ||
| 14-Day RSI | 93.05 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.00001 - 0.0001 | ||
| Shares Outstanding (Mil) | 1.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Poniard Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Poniard Pharmaceuticals Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.025:1 Stock Split | 2011-11-23 | 5.97 (-25.35%) | ||
| 0.1667:1 Stock Split | 2006-09-25 | 136.77 (+0.00%) | ||
| 0.25:1 Stock Split | 1993-12-14 | 2,009.65 (+0.00%) |
Show
Entries
Poniard Pharmaceuticals Inc Frequently Asked Questions
What is Poniard Pharmaceuticals Inc(PARD)'s stock price today?
The current price of PARD is $0.00. The 52 week high of PARD is $0.00 and 52 week low is $0.00.
When is next earnings date of Poniard Pharmaceuticals Inc(PARD)?
The next earnings date of Poniard Pharmaceuticals Inc(PARD) is .
Does Poniard Pharmaceuticals Inc(PARD) pay dividends? If so, how much?
Poniard Pharmaceuticals Inc(PARD) does not pay dividend.
Guru Commentaries on OTCPK:PARD
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Poniard Pharmaceuticals Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers